vs

Side-by-side financial comparison of CASTLE BIOSCIENCES INC (CSTL) and Nine Energy Service, Inc. (NINE). Click either name above to swap in a different company.

CASTLE BIOSCIENCES INC is the larger business by last-quarter revenue ($83.7M vs $41.6M, roughly 2.0× Nine Energy Service, Inc.). Nine Energy Service, Inc. runs the higher net margin — 259.3% vs -17.4%, a 276.7% gap on every dollar of revenue. On growth, CASTLE BIOSCIENCES INC posted the faster year-over-year revenue change (-4.9% vs -68.5%). Over the past eight quarters, CASTLE BIOSCIENCES INC's revenue compounded faster (-1.9% CAGR vs -43.9%).

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

Xcel Energy Inc. is a U.S. regulated electric utility and natural gas delivery company based in Minneapolis, Minnesota, serving approximately 3.9 million electricity customers and 2.2 million natural gas customers across parts of eight states as of mid-2025. It consists of four operating subsidiaries: Northern States Power-Minnesota, Northern States Power-Wisconsin, Public Service Company of Colorado, and Southwestern Public Service Co.

CSTL vs NINE — Head-to-Head

Bigger by revenue
CSTL
CSTL
2.0× larger
CSTL
$83.7M
$41.6M
NINE
Growing faster (revenue YoY)
CSTL
CSTL
+63.6% gap
CSTL
-4.9%
-68.5%
NINE
Higher net margin
NINE
NINE
276.7% more per $
NINE
259.3%
-17.4%
CSTL
Faster 2-yr revenue CAGR
CSTL
CSTL
Annualised
CSTL
-1.9%
-43.9%
NINE

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CSTL
CSTL
NINE
NINE
Revenue
$83.7M
$41.6M
Net Profit
$-14.5M
$107.9M
Gross Margin
9.1%
Operating Margin
Net Margin
-17.4%
259.3%
Revenue YoY
-4.9%
-68.5%
Net Profit YoY
43.8%
EPS (diluted)
$-0.49
$2.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSTL
CSTL
NINE
NINE
Q1 26
$83.7M
$41.6M
Q4 25
$87.0M
$132.2M
Q3 25
$83.0M
$132.0M
Q2 25
$86.2M
$147.3M
Q1 25
$88.0M
$150.5M
Q4 24
$86.3M
$141.4M
Q3 24
$85.8M
$138.2M
Q2 24
$87.0M
$132.4M
Net Profit
CSTL
CSTL
NINE
NINE
Q1 26
$-14.5M
$107.9M
Q4 25
$-19.2M
Q3 25
$-501.0K
$-14.6M
Q2 25
$4.5M
$-10.4M
Q1 25
$-25.8M
$-7.1M
Q4 24
$-8.8M
Q3 24
$2.3M
$-10.1M
Q2 24
$8.9M
$-14.0M
Gross Margin
CSTL
CSTL
NINE
NINE
Q1 26
9.1%
Q4 25
79.0%
Q3 25
77.5%
Q2 25
79.5%
Q1 25
81.4%
Q4 24
81.3%
Q3 24
81.8%
Q2 24
83.3%
Operating Margin
CSTL
CSTL
NINE
NINE
Q1 26
Q4 25
-4.4%
-4.2%
Q3 25
-8.2%
-0.9%
Q2 25
-4.9%
2.3%
Q1 25
-31.7%
3.7%
Q4 24
4.7%
2.5%
Q3 24
5.9%
1.8%
Q2 24
5.8%
-1.1%
Net Margin
CSTL
CSTL
NINE
NINE
Q1 26
-17.4%
259.3%
Q4 25
-14.5%
Q3 25
-0.6%
-11.1%
Q2 25
5.2%
-7.1%
Q1 25
-29.4%
-4.7%
Q4 24
-6.3%
Q3 24
2.6%
-7.3%
Q2 24
10.3%
-10.6%
EPS (diluted)
CSTL
CSTL
NINE
NINE
Q1 26
$-0.49
$2.65
Q4 25
$-0.06
$-0.47
Q3 25
$-0.02
$-0.35
Q2 25
$0.15
$-0.25
Q1 25
$-0.90
$-0.18
Q4 24
$0.32
$-0.21
Q3 24
$0.08
$-0.26
Q2 24
$0.31
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSTL
CSTL
NINE
NINE
Cash + ST InvestmentsLiquidity on hand
$63.8M
$11.2M
Total DebtLower is stronger
$10.1M
$94.4M
Stockholders' EquityBook value
$461.4M
Total Assets
$547.8M
$326.0M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSTL
CSTL
NINE
NINE
Q1 26
$63.8M
$11.2M
Q4 25
$299.5M
$18.4M
Q3 25
$287.5M
$14.4M
Q2 25
$275.9M
$14.2M
Q1 25
$275.2M
$17.3M
Q4 24
$293.1M
$27.9M
Q3 24
$95.0M
$15.7M
Q2 24
$85.6M
$26.0M
Total Debt
CSTL
CSTL
NINE
NINE
Q1 26
$10.1M
$94.4M
Q4 25
$10.1M
Q3 25
$10.0M
Q2 25
$10.0M
Q1 25
$10.0M
Q4 24
$10.0M
Q3 24
$10.0M
Q2 24
$10.0M
Stockholders' Equity
CSTL
CSTL
NINE
NINE
Q1 26
$461.4M
Q4 25
$470.9M
$-115.0M
Q3 25
$467.0M
$-95.9M
Q2 25
$455.4M
$-81.7M
Q1 25
$440.3M
$-72.1M
Q4 24
$455.8M
$-66.1M
Q3 24
$441.1M
$-57.6M
Q2 24
$423.9M
$-49.7M
Total Assets
CSTL
CSTL
NINE
NINE
Q1 26
$547.8M
$326.0M
Q4 25
$578.6M
$339.5M
Q3 25
$562.8M
$340.7M
Q2 25
$544.7M
$361.2M
Q1 25
$501.7M
$359.2M
Q4 24
$531.2M
$360.1M
Q3 24
$514.6M
$353.2M
Q2 24
$487.3M
$381.7M
Debt / Equity
CSTL
CSTL
NINE
NINE
Q1 26
0.02×
Q4 25
0.02×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSTL
CSTL
NINE
NINE
Operating Cash FlowLast quarter
$-22.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSTL
CSTL
NINE
NINE
Q1 26
$-22.1M
Q4 25
$26.9M
$-2.2M
Q3 25
$22.6M
$-9.9M
Q2 25
$20.8M
$10.1M
Q1 25
$-6.0M
$-5.3M
Q4 24
$24.4M
$15.0M
Q3 24
$23.3M
$-5.8M
Q2 24
$24.0M
$12.9M
Free Cash Flow
CSTL
CSTL
NINE
NINE
Q1 26
Q4 25
$19.7M
$-4.8M
Q3 25
$7.8M
$-13.4M
Q2 25
$11.6M
$4.2M
Q1 25
$-10.8M
$-9.3M
Q4 24
$16.8M
$11.8M
Q3 24
$17.0M
$-9.3M
Q2 24
$18.8M
$10.3M
FCF Margin
CSTL
CSTL
NINE
NINE
Q1 26
Q4 25
22.7%
-3.6%
Q3 25
9.4%
-10.2%
Q2 25
13.4%
2.9%
Q1 25
-12.2%
-6.2%
Q4 24
19.5%
8.3%
Q3 24
19.8%
-6.7%
Q2 24
21.6%
7.7%
Capex Intensity
CSTL
CSTL
NINE
NINE
Q1 26
Q4 25
8.3%
2.0%
Q3 25
17.9%
2.6%
Q2 25
10.7%
4.0%
Q1 25
5.4%
2.6%
Q4 24
8.8%
2.3%
Q3 24
7.4%
2.5%
Q2 24
6.0%
2.0%
Cash Conversion
CSTL
CSTL
NINE
NINE
Q1 26
Q4 25
Q3 25
Q2 25
4.60×
Q1 25
Q4 24
Q3 24
10.29×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons